Welcome to our dedicated page for Optimizerx news (Ticker: OPRX), a resource for investors and traders seeking the latest updates and insights on Optimizerx stock.
OptimizeRx Corp (NASDAQ: OPRX) provides a dedicated news hub for tracking developments in healthcare technology and digital patient engagement solutions. This page aggregates official announcements, financial disclosures, and strategic updates from the leader in EHR-integrated pharma messaging.
Investors and industry professionals will find curated coverage of earnings reports, technology partnerships, product launches, and regulatory milestones. The resource serves as a centralized source for understanding OPRX's role in connecting pharmaceutical companies with healthcare providers through cloud-based communication platforms.
Key content categories include financial results, strategic alliances with EHR providers, technology innovations in digital health messaging, and industry recognition of platform advancements. All materials maintain factual accuracy and timeliness required for informed decision-making.
Bookmark this page for streamlined access to OptimizeRx's evolving position in medication adherence solutions and AI-driven healthcare communications. Regular updates ensure stakeholders stay informed about developments impacting the digital pharma marketing landscape.
OptimizeRx Corp. (Nasdaq: OPRX), a leader in digital health solutions, is set to participate in two key investor conferences in September. The first event is the H.C. Wainwright’s 22nd Annual Global Investment Conference from September 14-16, featuring 1x1 meetings and a live webcast on September 16 at 1:00 p.m. EDT. The second event is the Lake Street Capital Markets’ 4th Annual Best Ideas Growth Conference on September 17, emphasizing further engagement with institutional investors.
Management will highlight the expansion of its digital health platform and its new FDA-cleared Smart Health Stations, enhancing communication between life science companies, healthcare providers, and patients.
OptimizeRx Corp. (NASDAQ: OPRX) has been invited to present at the LD 500 virtual investor conference from September 1-4, 2020. CEO William Febbo will present on September 3 at 12:20 p.m. Eastern time and will engage in one-on-one meetings with institutional investors. The conference will showcase over 300 micro-cap companies and feature discussions relevant to investors. OptimizeRx aims to highlight its digital health solutions that enhance communication between life science companies, physicians, and patients, particularly with its new network of 10,000 Smart Health Stations.
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its digital health communication network in partnership with Change Healthcare (Nasdaq: CHNG). This collaboration enhances access to vital healthcare information for providers, enabling them to deliver real-time updates on drug savings and treatment options during patient consultations. The integration supports better patient-provider communication, aiming to improve patient outcomes. The Intelligent Healthcare Network™ by Change Healthcare processes 14 billion transactions annually, showcasing a robust platform for data exchange.
OptimizeRx Corp. (Nasdaq: OPRX) will hold a conference call on August 5, 2020, at 4:30 p.m. ET to discuss its Q2 2020 results. The call will be hosted by management, following the release of financial results. Interested participants can dial in using the provided toll-free and international numbers. A replay will be available after the call and can be accessed via the OptimizeRx website. The company specializes in digital health solutions for life sciences and payers, improving communication and patient engagement within healthcare.
OptimizeRx Corp. (Nasdaq: OPRX) has appointed Greg Wasson, former president and CEO of Walgreens Boots Alliance, to its board of directors. This strategic move aims to bolster patient connectivity and enhance digital health services. Wasson, credited for achieving $76.4 billion in sales at Walgreens, brings extensive experience in organizational change and leadership. CEO William Febbo highlighted the growing need for affordability and adherence in digital health, making Wasson's expertise crucial for the company's future growth.
OptimizeRx Corp. (Nasdaq: OPRX) announced securing two new enterprise-level SaaS engagements, one from a new client and another transitioning from a legacy system, averaging an annual contract value of $3.6 million. The company highlights strong revenue potential from converting legacy clients to its enterprise platform, estimating over $100 million in upsell opportunities. CEO William Febbo noted the increasing demand for their digital health solutions amid COVID-19, enhancing communication among pharmaceutical companies, healthcare providers, and patients, thereby improving medication affordability and adherence.
OptimizeRx Corp. (Nasdaq: OPRX) has appointed UHY LLP as its new auditor effective June 22, 2020. This change aims to enhance audit efficiency, particularly by reducing travel costs in light of COVID-19. The company reported two previous weaknesses in internal control, which have not impacted financial results. OptimizeRx has also renewed its membership in the Russell Microcap and 3000 Indexes, signifying growth and visibility in the market. CEO William Febbo noted this growth comes alongside record Q1 results and an increasing customer base with major health systems and pharmaceutical companies.
OptimizeRx Corp. (NASDAQ: OPRX) has expanded its digital communication platform by partnering with over 300 health systems and 75,000 healthcare providers using Epic and Cerner EHRs. This partnership will enhance immediate access to real-time patient savings information, aiming to address medication non-adherence, which costs the healthcare system $528 billion annually. The expansion connects OptimizeRx to an additional 120 million patients, increasing its network reach to over 675,000 prescribers. This growth represents an 11% increase in the largest point-of-prescribe network focused on improving treatment adherence.
OptimizeRx Corp. (Nasdaq: OPRX), a digital health leader, will present at William Blair & Company’s 40th Annual Growth Stock Conference from June 9-11, 2020. CEO William Febbo is set to speak on June 10 at 9:20 a.m. Central time, highlighting the company's record Q1 results and the relevance of its platform during COVID-19. The presentation will be live-streamed for institutional clients.
OptimizeRx Corp. (Nasdaq: OPRX) has been invited to present at RBC Capital Markets' virtual Global Healthcare Conference on May 19-20, 2020. CEO William Febbo will present on May 19 at 8:35 a.m. ET, covering the company’s record Q1 results and its digital health network, which reaches 60% of the ambulatory market. The conference will explore healthcare innovation post-COVID-19. Institutional clients of RBC can attend, and the presentation will be available for live viewing on the investor's website.
